Peres Jepchirchir provisionally banned for EPO after Sydney Marathon win – implications for Kenyan running in 2026

Background: Jepchirchir’s rise and the Sydney triumph

Peres Jepchirchir burst onto the global stage with a gold medal in the women’s 10,000 metres at the 2022 World Championships, quickly becoming Kenya’s poster child for long‑distance dominance. She built on that reputation with a series of high‑profile road victories, most notably the New York City Marathon in 2023 and the Boston Marathon in 2024, cementing her status as a consistent podium finisher.

In August 2026, Jepchirchir entered the Sydney Marathon as the overwhelming favourite, carrying a $250,000 prize purse and a lucrative sponsorship deal with a multinational sportswear brand. She delivered a spectacular performance, crossing the line in 2:18:34 – the fastest time recorded on the Australian course in a decade – and added another major win to her résumé.

The win was celebrated across Kenya, with the Ministry of Sports hailing her as a symbol of national pride and a role model for young athletes. Her success also boosted tourism promotion campaigns that linked Kenya’s high‑altitude training hubs to elite performance, a narrative that has long underpinned the country’s athletics export market.

The positive test and provisional suspension

The Athletics Integrity Unit (AIU) announced on 20 October 2026 that a urine sample taken from Jepchirchir on 10 August, the day before the Sydney race, tested positive for erythropoietin (EPO), a banned blood‑boosting agent. The AIU said the result was confirmed by a secondary laboratory analysis and that the athlete had been provisionally suspended pending a hearing.

According to the AIU’s statement, Jepchirchir was notified of the provisional ban on 18 October and was immediately barred from competing in any AIU‑sanctioned event, including the upcoming World Athletics Championships in Budapest and the 2028 Olympic Games. The athlete’s legal team has filed a request for a B‑sample analysis, a standard procedure that could either uphold or overturn the initial finding.

Kenyan Athletics Federation (KAF) president Jackson Kiplagat said the federation would cooperate fully with the AIU while also ensuring that Jepchirchir receives a fair process. He added that the federation would launch an internal review of its anti‑doping education programme, which has been criticised for gaps in athlete support.

Why the case matters for Kenyan distance running

Kenya’s dominance in middle‑ and long‑distance events has long been a source of both national pride and international scrutiny. A high‑profile doping case involving a marquee athlete like Jepchirchir threatens to erode the credibility that Kenyan runners have painstakingly built over decades.

The provisional ban arrives at a time when Kenyan athletes are negotiating new endorsement contracts and seeking entry into lucrative road‑race circuits in the United States, Europe, and the Middle East. Sponsors are increasingly wary of reputational risk, and a single scandal can trigger contract renegotiations or terminations, as seen in previous cases involving Kenyan sprinter Faith Kipyegon’s former coach.

Moreover, the case could influence the selection policies for upcoming championships. If the AIU’s final decision confirms a doping violation, KAF may be forced to tighten its eligibility criteria, potentially sidelining athletes who have been on the cusp of selection and reshaping the composition of Kenya’s elite squads for the 2028 Olympics.

Broader doping trends in East African athletics

Jepchirchir’s alleged EPO use is part of a worrying uptick in doping violations among East African runners over the past five years. According to a 2025 World Anti‑Doping Agency (WADA) report, the number of adverse analytical findings in Kenya rose by 22 % between 2020 and 2024, with blood‑boosting substances accounting for the majority of positive cases.

Experts attribute the rise to a combination of factors: the growing financial incentives tied to marathon winnings, the proliferation of underground coaching networks, and gaps in the national anti‑doping infrastructure. A former Kenyan coach, speaking on condition of anonymity, suggested that some athletes feel pressured to resort to performance‑enhancing drugs to keep pace with the ever‑tightening margins at the elite level.

The AIU has responded by increasing out‑of‑competition testing in Kenya’s high‑altitude training camps, deploying portable testing kits and partnering with local universities for sample analysis. While the intensified scrutiny is welcomed by clean‑sport advocates, it also raises concerns about privacy and the potential for false positives in regions where medical resources are limited.

Reactions from athletes, sponsors and officials

Fellow Kenyan marathoners, including world record holder Brigid Kosgei, expressed disappointment but urged caution, stating that “one case should not tarnish the reputation of an entire nation.” Kosgei, who has also faced unfounded doping rumors in the past, highlighted the need for a robust support system that protects athletes from both illicit substances and false accusations.

International sponsors reacted swiftly. The sportswear brand that had signed Jepchirchir to a multi‑year deal placed a temporary hold on her contract, citing its “zero‑tolerance policy on doping.” The brand’s spokesperson said the company would reassess the partnership after the AIU’s final ruling, a move that underscores how commercial interests are now tightly linked to anti‑doping outcomes.

Kenyan political leaders, including the Minister of Sports, called for a national dialogue on clean sport. In a televised interview, the minister pledged additional funding for anti‑doping education in schools and urged diaspora athletes to serve as ambassadors for integrity, noting that the Kenyan diaspora in the United States and Europe often competes in high‑visibility races that shape global perceptions of African athletics.

What’s next: legal battle, championships and the sport’s image

The next procedural step is the B‑sample analysis, scheduled for early November 2026. If the B‑sample confirms the presence of EPO, Jepchirchir faces a potential four‑year ban, which would bar her from the 2028 Olympic Games and likely end her competitive career. Her legal team, led by former athlete‑turned‑lawyer Aisha Mwangi, has indicated they will challenge the testing protocol, arguing that “chain‑of‑custody” procedures were not fully observed in the remote Sydney collection site.

Regardless of the outcome, the case will influence the selection dynamics for the Budapest World Championships later this year. Kenya’s women’s marathon team, traditionally a strong medal contender, may have to field a less‑experienced lineup, opening opportunities for rising stars such as 22‑year‑old Ruth Chebet from the Rift Valley.

In the longer term, the incident could accelerate reforms within Kenyan athletics. Stakeholders are already discussing the creation of a national anti‑doping centre that would operate independently of the federation, mirroring models used in South Africa and Ethiopia. If implemented, such a centre could restore confidence among international race organizers, sponsors, and the global fan base, ensuring that Kenya’s running legacy remains a source of inspiration rather than controversy.

Quick Answers

Why was Peres Jepchirchir provisionally banned?
The Athletics Integrity Unit said a sample taken on 10 August 2026 tested positive for the banned blood‑booster EPO, leading to a provisional suspension.

How could the ban affect Kenya’s marathon team at the 2026 World Championships?
If the ban is upheld, Jepchirchir will miss the championships, forcing Kenya to replace her with a less‑experienced runner and potentially weakening its medal prospects.

What steps is Kenya taking to combat doping after recent violations?
Kenya’s athletics federation plans to boost out‑of‑competition testing, launch a national anti‑doping education programme, and consider establishing an independent anti‑doping centre.

Source: www.aljazeera.com